Neoadjuvantes FOLFIRINOX vs. neoadjuvante Radiochemotherapie und adjuvante Chemotherapie mit Gemcitabin für resektable und borderline-resektable Pankreaskarzinome (PREOPANC-2-Studie)

Strahlentherapie und Onkologie 2026

View at publisher

Authors: Günther Klautke

DOI: 10.1007/s00066-025-02500-1

Cited by: 0

References: 12

Fields of Study & Subjects

Pancreatic and Hepatic Oncology Research Neuroendocrine Tumor Research Advances Cholangiocarcinoma and Gallbladder Cancer Studies

References 12